Literature DB >> 10648052

Using the Larsen index to assess radiographic progression in rheumatoid arthritis.

J R Kirwan1.   

Abstract

To describe the Larsen index and its strengths and weaknesses. I reviewed the original publication, a number of published modifications, tests of reproducibility, and some clinical studies that have used the index. The Larsen index is essentially a grading of erosion severity that has satisfactory reproducibility for use in groups of patients. The Larsen index can clearly distinguish different rates of erosive progression in groups of patients with different characteristics or treatments. Recent studies using the Larsen index have identified clear treatment effects. Difficulty in measuring the success of previous treatments designed to hold back the progression of erosions relates to the inefficacy of those treatments, not insensitivity of the Larsen index.

Entities:  

Mesh:

Year:  2000        PMID: 10648052

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

Authors:  V P K Nell; K P Machold; T A Stamm; G Eberl; H Heinzl; M Uffmann; J S Smolen; G Steiner
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

2.  Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial.

Authors:  Sarah Hewlett; John Kirwan; Jon Pollock; Kathryn Mitchell; Maggie Hehir; Peter S Blair; David Memel; Mark G Perry
Journal:  BMJ       Date:  2004-11-16

3.  Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.

Authors:  Raimon Sanmartí; Eduard Graell; Maria L Perez; Guadalupe Ercilla; Odette Viñas; Jose A Gómez-Puerta; Jordi Gratacós; Alejandro Balsa; Maria J Gómara; Marta Larrosa; Juan D Cañete; Isabel Haro
Journal:  Arthritis Res Ther       Date:  2009-09-02       Impact factor: 5.156

4.  Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients.

Authors:  Cristina García-Moreno; María J Gómara; Raúl Castellanos-Moreira; Raimon Sanmartí; Isabel Haro
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

5.  Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.

Authors:  R Sanmartí; A Gómez-Centeno; G Ercilla; M Larrosa; O Viñas; I Vazquez; J A Gómez-Puerta; J Gratacós; G Salvador; J D Cañete
Journal:  Clin Rheumatol       Date:  2006-11-16       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.